Early-onset Dementia
Gene: SPG21
Mast syndrome is an autosomal recessive complicated form of hereditary spastic paraplegia in which progressive spastic paraparesis is associated in more advanced cases with cognitive decline, dementia, and other neurologic abnormalities. Symptom onset usually occurs in adulthood, and the disorder is progressive with variable severity. Brain imaging shows thinning of the corpus callosum. The disorder occurs with high frequency in the Old Order Amish. Founder variant in Amish, two additional families and a mouse model.
New HGNC approved gene name is ACP33Created: 25 Sep 2020, 2:48 a.m. | Last Modified: 25 Sep 2020, 2:51 a.m.
Panel Version: 0.110
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Mast syndrome, MIM# 248900
Publications
Tag new gene name tag was added to gene: SPG21.
Gene: spg21 has been classified as Green List (High Evidence).
Phenotypes for gene: SPG21 were changed from to Mast syndrome, MIM# 248900
Publications for gene: SPG21 were set to
Mode of inheritance for gene: SPG21 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal
gene: SPG21 was added gene: SPG21 was added to Early-onset Dementia_MGHA_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services,Melbourne Genomics Health Alliance Complex Neurology Flagship Mode of inheritance for gene: SPG21 was set to Unknown